Key facts
- Q Shield’s last known valuation is $230.0M (May 2020).
- It has raised $3.4M; the latest was Later Stage VC ($180K) in Sep 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Q Shield
- ·The full record, as it builds
Funding rounds
No funding rounds for Q Shield are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Q Shield
Producer of hand sanitizers and surface disinfectant products intended to improve hygiene and safety among people. The company's products offer UVC disinfection that kills pathogens reducing the risk of spreading deadly diseases, enabling customers to maintain a cleaner and safer healthcare environment in a fast and cost-effective manner.
- Sector
- Healthcare
- HQ
- Libertyville, IL, United States
- Founded
- 2017
- Employees
- 5
- Website
- axenic.com/
- Ownership
- Privately Held (backing)
Q Shield doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Q Shield shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Q Shield in its N-PORT filings yet. We sweep new filings monthly.